or Try an Advanced Search...

    Technical Analysis for ZLAB - Zai Lab Limited

    Grade Last Price % Change Price Change
    D 24.00 -4.99% -1.26
    ZLAB closed down 4.99 percent on Thursday, September 28, 2023, on 78 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ZLAB trend table...
    Date Alert Name Type % Chg
    Gapped Down Weakness 0.00%
    Pocket Pivot Bullish Swing Setup -4.99%
    Gapped Up Strength -4.99%
    Up 3 Days in a Row Strength -4.99%
    Up 4 Days in a Row Strength -4.99%
    Oversold Stochastic Weakness -4.99%
    Stochastic Buy Signal Bullish -3.69%
    Up 3 Days in a Row Strength -3.69%
    Gapped Down Weakness -3.69%
    Oversold Stochastic Weakness -3.69%
    Older End-of-Day Signals for ZLAB ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Down 5% about 14 hours ago
    Fell Below Lower Bollinger Band about 14 hours ago
    Lower Bollinger Band Support about 14 hours ago
    Down 1 ATR about 14 hours ago
    Gapped Down (Full) about 14 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ZLAB Chart by TradingView
    Basic chart:

    Profile

    Zai Lab Ltd, incorporated on March 28, 2017, is a biopharmaceutical company. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include three drug candidates with greater China rights and three drug candidates with global rights. The greater China rights drug candidates include Niraparib (ZL-2306), Omadacycline (ZL-2401) and ZL-2301. The global rights drug candidates include Fugan (ZL-3101), ZL-2302 and ZL-1101.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Natural Sciences Infectious Diseases Medication Chemical Substances Autoimmune And Infectious Diseases Omadacycline

    Is ZLAB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 5 Why Shares of Zai Lab Limited Were Jumping on Tuesday
    Sep 5 Seagen's (SGEN) Late-Stage Cervical Cancer Study Meets Goals
    Sep 5 Biggest stock movers today: Airbnb, Blackstone, NextGen Healthcare and more
    Aug 31 Zai Lab (ZLAB) Up on Breakthrough Therapy Tag for Oncology Drug
    Aug 30 Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib for Treatment of Patients with NTRK-positive TKI-pretreated advanced solid tumors in China
    Aug 29 Zai Lab Announces Participation in September Investor Conferences
    Aug 9 Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday
    Aug 8 Zai Lab Limited (ZLAB) Q2 2023 Earnings Call Transcript
    Aug 7 Zai Lab GAAP EPS of -$1.25 misses by $0.50, revenue of $68.86M misses by $1.81M
    Aug 7 Zai Lab Announces Second Quarter 2023 Financial Results and Corporate Updates
    See more ZLAB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 49.81
    52 Week Low 20.98
    Average Volume 416,627
    200-Day Moving Average 32.52
    50-Day Moving Average 26.23
    20-Day Moving Average 25.79
    10-Day Moving Average 24.97
    Average True Range 1.41
    RSI (14) 41.52
    ADX 10.28
    +DI 22.95
    -DI 30.31
    Chandelier Exit (Long, 3 ATRs) 25.41
    Chandelier Exit (Short, 3 ATRs) 26.92
    Upper Bollinger Bands 28.19
    Lower Bollinger Band 23.39
    Percent B (%b) 0.13
    BandWidth 18.61
    MACD Line -0.40
    MACD Signal Line -0.29
    MACD Histogram -0.1069
    Fundamentals Value
    Market Cap 2.11 Billion
    Num Shares 88 Million
    EPS -3.12
    Price-to-Earnings (P/E) Ratio -7.70
    Price-to-Sales 268.12
    Price-to-Book 20.60
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 25.33
    Resistance 3 (R3) 25.33 24.89 25.11
    Resistance 2 (R2) 24.89 24.56 24.89 25.03
    Resistance 1 (R1) 24.45 24.35 24.23 24.44 24.96
    Pivot Point 24.01 24.01 23.90 24.01 24.01
    Support 1 (S1) 23.56 23.67 23.34 23.56 23.04
    Support 2 (S2) 23.12 23.46 23.12 22.97
    Support 3 (S3) 22.68 23.12 22.89
    Support 4 (S4) 22.67